Vaccinex Short Term Debt from 2010 to 2024

VCNX Stock  USD 3.69  0.13  3.65%   
Vaccinex Short Term Debt yearly trend continues to be fairly stable with very little volatility. Short Term Debt will likely drop to about 348.6 K in 2024. During the period from 2010 to 2024, Vaccinex Short Term Debt regression line of annual values had r-squared of  0.02 and arithmetic mean of  2,375,110. View All Fundamentals
 
Short Term Debt  
First Reported
2016-12-31
Previous Quarter
181 K
Current Value
59 K
Quarterly Volatility
2.4 M
 
Covid
Check Vaccinex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaccinex's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 19.7 K or Depreciation And Amortization of 181 K, as well as many indicators such as Price To Sales Ratio of 7.19, Dividend Yield of 0.0 or Days Sales Outstanding of 451. Vaccinex financial statements analysis is a perfect complement when working with Vaccinex Valuation or Volatility modules.
  
Check out the analysis of Vaccinex Correlation against competitors.
For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide.

Latest Vaccinex's Short Term Debt Growth Pattern

Below is the plot of the Short Term Debt of Vaccinex over the last few years. It is Vaccinex's Short Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaccinex's overall financial position and show how it may be relating to other accounts over time.
Short Term Debt10 Years Trend
Pretty Stable
   Short Term Debt   
       Timeline  

Vaccinex Short Term Debt Regression Statistics

Arithmetic Mean2,375,110
Geometric Mean1,225,483
Coefficient Of Variation126.74
Mean Deviation2,337,941
Median1,037,000
Standard Deviation3,010,171
Sample Variance9.1T
Range7.9M
R-Value0.14
Mean Square Error9.6T
R-Squared0.02
Significance0.61
Slope96,145
Total Sum of Squares126.9T

Vaccinex Short Term Debt History

2024348.6 K
2023367 K
2022402 K
2021215 K
20188.1 M
20172.8 M

About Vaccinex Financial Statements

Vaccinex investors use historical fundamental indicators, such as Vaccinex's Short Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Vaccinex. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short Term Debt367 K348.6 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Vaccinex Stock Analysis

When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.